• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1074300-38
Device Problem Expulsion (2933)
Patient Problem Stenosis (2263)
Event Date 08/02/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information.Implant date has been estimated.The device was not returned for evaluation.A review of the lot history record could not be performed as the lot number was not provided.The reported patient effect of stenosis is listed in the xience xpedition, ce eluting coronary stent systems (eccs) instructions for use, as a known patient effect.A conclusive cause for the reported patient effect and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The additional xience xpedition device is being file under a separate medwatch report.
 
Event Description
It was reported that in (b)(6) 2018, the procedure was performed using two xience xpedition stents to treat a lesion in the mid right coronary artery (rca) with mild calcification.A 3.0 x 38 mm xience xpedition stent was implanted in the proximal rca and a 3.0 x 18 mm xience xpedition stent was implanted in the mid rca.On (b)(6) 2018, the patient presented with acute coronary syndrome from a de novo blockage.Angiography revealed the stents had 70-80% restenosis in the rca in both xience xpedition stents.Balloon angioplasty was performed to treat the restenosis.Per the physician, the cause of the restenosis was under expansion of the stent.The left anterior artery was also treated.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7819670
MDR Text Key118329204
Report Number2024168-2018-06620
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648162381
UDI-Public08717648162381
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 08/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1074300-38
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/02/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STENT: XIENCE XPEDITION
Patient Outcome(s) Required Intervention;
-
-